Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration.

Meitinger F, Anzola JV, Kaulich M, Richardson A, Stender JD, Benner C, Glass CK, Dowdy SF, Desai A, Shiau AK, Oegema K.

J Cell Biol. 2016 Jul 18;214(2):155-66. doi: 10.1083/jcb.201604081.

2.

A Cell Biologist's Field Guide to Aurora Kinase Inhibitors.

de Groot CO, Hsia JE, Anzola JV, Motamedi A, Yoon M, Wong YL, Jenkins D, Lee HJ, Martinez MB, Davis RL, Gahman TC, Desai A, Shiau AK.

Front Oncol. 2015 Dec 21;5:285. doi: 10.3389/fonc.2015.00285. eCollection 2015.

3.

Cell biology. Reversible centriole depletion with an inhibitor of Polo-like kinase 4.

Wong YL, Anzola JV, Davis RL, Yoon M, Motamedi A, Kroll A, Seo CP, Hsia JE, Kim SK, Mitchell JW, Mitchell BJ, Desai A, Gahman TC, Shiau AK, Oegema K.

Science. 2015 Jun 5;348(6239):1155-60. doi: 10.1126/science.aaa5111. Epub 2015 Apr 30.

4.

Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases.

Symons KT, Nguyen PM, Massari ME, Anzola JV, Staszewski LM, Wang L, Yazdani N, Dorow S, Muhammad J, Sablad M, Rozenkrants N, Bonefous C, Payne JE, Rix PJ, Shiau AK, Noble SA, Smith ND, Hassig CA, Zhang Y, Rao TS.

J Pharmacol Exp Ther. 2011 Feb;336(2):468-78. doi: 10.1124/jpet.110.172817. Epub 2010 Oct 29.

PMID:
21036913
5.

Water-soluble PDE4 inhibitors for the treatment of dry eye.

Govek SP, Oshiro G, Anzola JV, Beauregard C, Chen J, Coyle AR, Gamache DA, Hellberg MR, Hsien JN, Lerch JM, Liao JC, Malecha JW, Staszewski LM, Thomas DJ, Yanni JM, Noble SA, Shiau AK.

Bioorg Med Chem Lett. 2010 May 1;20(9):2928-32. doi: 10.1016/j.bmcl.2010.03.023. Epub 2010 Mar 7.

PMID:
20378348
6.

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo.

Hassig CA, Symons KT, Guo X, Nguyen PM, Annable T, Wash PL, Payne JE, Jenkins DA, Bonnefous C, Trotter C, Wang Y, Anzola JV, Milkova EL, Hoffman TZ, Dozier SJ, Wiley BM, Saven A, Malecha JW, Davis RL, Muhammad J, Shiau AK, Noble SA, Rao TS, Smith ND, Hager JH.

Mol Cancer Ther. 2008 May;7(5):1054-65. doi: 10.1158/1535-7163.MCT-07-2347.

7.
8.
9.

Complete nucleotide sequence of wound tumor virus genomic segments encoding nonstructural polypeptides.

Anzola JV, Dall DJ, Xu ZK, Nuss DL.

Virology. 1989 Jul;171(1):222-8.

PMID:
2525838
11.

Complete nucleotide sequence of wound tumor virus genomic segment S11.

Dall DJ, Anzola JV, Xu Z, Nuss DL.

Nucleic Acids Res. 1989 May 11;17(9):3599. No abstract available.

12.

Complete nucleotide sequence of wound tumor virus genomic segment S7.

Anzola JV, Xu ZK, Nuss DL.

Nucleic Acids Res. 1989 Apr 25;17(8):3300. No abstract available.

14.
15.

Tailored removal of flanking homopolymer sequences from cDNA clones.

Xu ZK, Anzola JV, Nuss DL.

DNA. 1987 Oct;6(5):505-13.

PMID:
3677998
16.

Molecular cloning and characterization of the genome of wound tumor virus: a tumor-inducing plant reovirus.

Asamizu T, Summers D, Motika MB, Anzola JV, Nuss DL.

Virology. 1985 Jul 30;144(2):398-409.

PMID:
3840622

Supplemental Content

Loading ...
Support Center